Home | Business News | CBJ Newsmakers | ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors CBJ Newsmakers RecommendediSIGN Media Announces a Proposed Private Placement of $450,000ThreeD Capital Inc. Announces Unaudited May 31, 2021 Net Asset Value Per Share – $1.07DAVIDsTEA Creditors Approve CCAA Plan of Arrangement
